ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

European Chronic Obstructive Pulmonary Disease (COPD) Markets and Competitive Landscape Report 2021 - ResearchAndMarkets.com

September 10, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Sep 10, 2021--

The “Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2021” report has been added to ResearchAndMarkets.com’s offering.

Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2021, provides comprehensive insights into Chronic Obstructive Pulmonary Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.

This research analyzes and forecasts Chronic Obstructive Pulmonary Disease market size and drug sales. It also provides insights into Chronic Obstructive Pulmonary Disease epidemiology and late-stage pipeline.

ADVERTISEMENT

This research covers the following - Chronic Obstructive Pulmonary Disease treatment options, Chronic Obstructive Pulmonary Disease late-stage clinical trials pipeline, Chronic Obstructive Pulmonary Disease prevalence by countries, Chronic Obstructive Pulmonary Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Chronic Obstructive Pulmonary Disease pipeline: Find out drugs in clinical trials for the treatment of Chronic Obstructive Pulmonary Disease by development phase 3, phase 2, by pharmacological class and company
  • Chronic Obstructive Pulmonary Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Chronic Obstructive Pulmonary Disease by countries
  • Chronic Obstructive Pulmonary Disease drugs: Identify key drugs marketed and prescribed for Chronic Obstructive Pulmonary Disease in the US, including trade name, molecule name, and company
  • Chronic Obstructive Pulmonary Disease drugs sales: Find out the sales value for Chronic Obstructive Pulmonary Disease drugs by countries
  • Chronic Obstructive Pulmonary Disease market valuations: Find out the market size for Chronic Obstructive Pulmonary Disease drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026
  • Chronic Obstructive Pulmonary Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

ADVERTISEMENT

  • Evaluate commercial market opportunities for Chronic Obstructive Pulmonary Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Chronic Obstructive Pulmonary Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Chronic Obstructive Pulmonary Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in Chronic Obstructive Pulmonary Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/r/bo7twj

View source version on businesswire.com:https://www.businesswire.com/news/home/20210910005279/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 09/10/2021 08:24 AM/DISC: 09/10/2021 08:25 AM

http://www.businesswire.com/news/home/20210910005279/en